𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical and Molecular Characteristics of 35 Chinese Children with Wiskott–Aldrich Syndrome

✍ Scribed by Pamela P. W. Lee; Tong-Xin Chen; Li-Ping Jiang; Jing Chen; Koon-wing Chan; Tze-Leung Lee; Marco H. K. Ho; Shao-Han Nong; Yin Yang; Yong-Jun Fang; Qiang Li; Xiao-Chun Wang; Xi-Qiang Yang; Yu-Lung Lau

Publisher
Springer
Year
2009
Tongue
English
Weight
273 KB
Volume
29
Category
Article
ISSN
0271-9142

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of five novel WASP mutati
Identification of five novel WASP mutations in Chinese families with Wiskott-Aldrich syndrome
✍ Koon-Wing Chan; Tsz-Leung Lee; Brian Hon-Yin Chung; Xiqiang Yang; Yu-Lung Lau 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

The Wiskott-Aldrich Syndrome (WAS) is an X-linked recessive immunodeficiency caused by mutation in the gene encoding WAS protein (WASP). The disease is characterized by eczema, thrombocytopenia and severe immunodeificency and is associated with extensive clinical heterogeneity. Mutation studies indi

A new genetic isolate with a unique phen
A new genetic isolate with a unique phenotype of syndromic oculocutaneous albinism: clinical, molecular, and cellular characteristics
✍ Nira Schreyer-Shafir; Marjan Huizing; Yair Anikster; Ziva Nusinker; Idit Bejaran 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 528 KB

An extended, highly consanguineous Israeli Bedouin family with at least 20 individuals exhibiting a unique phenotype of oculocutaneous albinism (OCA) was identified. All known OCA genes were excluded in this family. Electron microscopic analysis of platelets revealed absence of dense bodies, suggest

Clinical characteristics and treatment o
Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and down's syndrome. A pediatric oncology group study
✍ Abdelsalam H. Ragab; Aly Abdel-Mageed; Jonathan J. Shuster; Lawrence S. Frankel; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 683 KB

Of 2947 children with acute lymphocytic leukemia (ALL), treated during three consecutive studies of the Pediatric Oncology Group (1974-1986), 52 (1.8%) had Down's Syndrome (DS). Comparison of clinical and laboratory characteristics showed no significant differences in leukocyte count, racial distrib